NCT00555074

Sodium Tungstate in Obesity

Efficacy of Oral Sodium Tungstate (200 mg/Day)on Weight Loss in Subjects With Grade I-II Obesity

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 44 (estimated)
• Sponsor: Hospital Clinic of Barcelona · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the efficacy and safety of sodium tungstate versus placebo in patients with obesity (grade I and II).

Conditions

• Obesity

Interventions

Type	Name	Description
DRUG	Sodium Tungstate	Sodium Tungstate, 200 mg BID, oral route during 6 weeks
DRUG	Placebo	Placebo, BID, oral route during 6 weeks

Timeline

• Start date: 2007-11-01
• Primary completion: 2009-05-01
• Completion: 2009-05-01
• First posted: 2007-11-07
• Last updated: 2010-03-31

Locations

1 site across 1 country: Spain